HomeTagsANDA

ANDA

Biotechnology

A.forall Announces the Launch of Their Fifth Abbreviated New Drug Application (ANDA) and Second “First Cycle” FDA Approval

News Desk - July 26, 2024

A.forall’s U.S. subsidiary Milla Pharmaceuticals Inc. announced the launch of the group’s generic version of Precedex, Dexmedetomidine Hydrochloride Injection 200 mcg per 50 mL...

Healthcare

Amneal Launches Authorized Generic for Xyrem® (sodium oxybate) and Receives FDA Approval for Five Complex Generics in the Second Quarter

News Desk - July 5, 2023

Amneal Pharmaceuticals, Inc. announced the launch of its authorized generic for Xyrem® (Sodium Oxybate) oral solution CIII in the United States. Sodium Oxybate oral solution,...